Caribou Biosciences (CRBU) Cash from Investing Activities (QoQ) (2020 - 2026)
Caribou Biosciences (CRBU) Cash from Investing Activities (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Caribou Biosciences | 152.90 Mn | 35.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.47% |
| Dec 31, 2025 | 65.61% |
| Sep 30, 2025 | -54.86% |
| Jun 30, 2025 | -51.33% |
| Mar 31, 2025 | 209.99% |
| Dec 31, 2024 | -39.93% |
| Sep 30, 2024 | 25.10% |
| Jun 30, 2024 | -7.65% |
| Mar 31, 2024 | 172.94% |
| Dec 31, 2023 | 54.04% |
| Sep 30, 2023 | -718.91% |
| Jun 30, 2023 | -46.56% |
| Mar 31, 2023 | 1,669.49% |
| Dec 31, 2022 | 114.03% |
| Sep 30, 2022 | 40.32% |
| Jun 30, 2022 | 80.62% |
| Mar 31, 2022 | 58.55% |
| Dec 31, 2021 | -8,913.52% |
| Sep 30, 2021 | -298.76% |
| Jun 30, 2021 | -2,100.00% |